American International Group, Inc. Kempharm, Inc Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	N/A	-153 Reduced 0.85%	17,923 $88,000
Q4 2023 Feb 13, 2024	BUY	N/A	1,094 Added 6.44%	18,076 $89,000
Q3 2023 Nov 13, 2023	BUY	N/A	285 Added 1.71%	16,982 $83,000
Q2 2023 Aug 04, 2023	BUY	$4.94 - $6.29 $82,483 - $105,024	16,697 New	16,697 $82,000
Q2 2022 Aug 12, 2022	SELL	$4.02 - $5.21 $59,158 - $76,670	-14,716 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.0 - $9.26 $5,180 - $9,593	-1,036 Reduced 6.58%	14,716 $74,000
Q4 2021 Feb 11, 2022	BUY	$7.6 - $10.26 $836 - $1,128	110 Added 0.7%	15,752 $137,000
Q3 2021 Nov 12, 2021	SELL	$8.72 - $13.31 $3,243 - $4,951	-372 Reduced 2.32%	15,642 $146,000
Q2 2021 Aug 13, 2021	BUY	$8.52 - $15.47 $136,439 - $247,736	16,014 New	16,014 $205,000

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.